Morgan Stanley’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,736,277
Closed -$35M 8334
2021
Q3
$35M Buy
1,736,277
+624,188
+56% +$12.6M ﹤0.01% 1557
2021
Q2
$41.5M Buy
1,112,089
+255,479
+30% +$9.53M 0.01% 1463
2021
Q1
$21.9M Buy
856,610
+801,509
+1,455% +$20.5M ﹤0.01% 1823
2020
Q4
$1.21M Buy
55,101
+43,736
+385% +$964K ﹤0.01% 4548
2020
Q3
$205K Sell
11,365
-21,419
-65% -$386K ﹤0.01% 5106
2020
Q2
$833K Buy
32,784
+3,893
+13% +$98.9K ﹤0.01% 4302
2020
Q1
$531K Sell
28,891
-122,944
-81% -$2.26M ﹤0.01% 4336
2019
Q4
$3.35M Buy
151,835
+132,568
+688% +$2.92M ﹤0.01% 3614
2019
Q3
$276K Sell
19,267
-6,064
-24% -$86.9K ﹤0.01% 4970
2019
Q2
$399K Buy
25,331
+5,149
+26% +$81.1K ﹤0.01% 4721
2019
Q1
$295K Sell
20,182
-72,822
-78% -$1.06M ﹤0.01% 4855
2018
Q4
$995K Buy
93,004
+14,989
+19% +$160K ﹤0.01% 4280
2018
Q3
$1.19M Sell
78,015
-20,857
-21% -$318K ﹤0.01% 4403
2018
Q2
$1.21M Buy
98,872
+84,510
+588% +$1.04M ﹤0.01% 4487
2018
Q1
$137K Buy
14,362
+12,488
+666% +$119K ﹤0.01% 5621
2017
Q4
$17K Buy
1,874
+685
+58% +$6.21K ﹤0.01% 6122
2017
Q3
$7K Sell
1,189
-57
-5% -$336 ﹤0.01% 6245
2017
Q2
$4K Sell
1,246
-24,523
-95% -$78.7K ﹤0.01% 6392
2017
Q1
$88K Sell
25,769
-10,975
-30% -$37.5K ﹤0.01% 5646
2016
Q4
$106K Sell
36,744
-440
-1% -$1.27K ﹤0.01% 5556
2016
Q3
$218K Sell
37,184
-3,773
-9% -$22.1K ﹤0.01% 4978
2016
Q2
$123K Buy
40,957
+26,919
+192% +$80.8K ﹤0.01% 5157
2016
Q1
$76K Sell
14,038
-130,896
-90% -$709K ﹤0.01% 5440
2015
Q4
$1.72M Sell
144,934
-118,873
-45% -$1.41M ﹤0.01% 3629
2015
Q3
$2.17M Buy
263,807
+252,489
+2,231% +$2.07M ﹤0.01% 3436
2015
Q2
$158K Buy
11,318
+4,400
+64% +$61.4K ﹤0.01% 5362
2015
Q1
$166K Sell
6,918
-4,146
-37% -$99.5K ﹤0.01% 5293
2014
Q4
$182K Sell
11,064
-38,036
-77% -$626K ﹤0.01% 5294
2014
Q3
$625K Buy
49,100
+40,661
+482% +$518K ﹤0.01% 4413
2014
Q2
$190K Sell
8,439
-16,572
-66% -$373K ﹤0.01% 5184
2014
Q1
$707K Buy
+25,011
New +$707K ﹤0.01% 4291